Edwards Lifesciences Common Stock, Shares, Outstanding decreased by 0.6% to 577M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.6%, from 586.2M to 577M. Over 5 years (FY 2020 to FY 2025), Common Stock, Shares, Outstanding shows relatively stable performance with a -1.4% CAGR.
An increase suggests share issuance (dilution), while a decrease indicates share buybacks (accretion).
This is the total number of shares currently held by all shareholders, including institutional investors and company ins...
Standard metric for all public companies; essential for valuation and ownership analysis.
other_common_stock_shares_outstanding| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 623.1M | 624.2M | 624.1M | 621.4M | 619.8M | 619.4M | 608.3M | 606M | 607.9M | 606.5M | 601.1M | 602.4M | 602.3M | 589.8M | 588.6M | 586.2M | 587.9M | 580.7M | 580.7M | 577M |
| QoQ Change | — | +0.2% | -0.0% | -0.4% | -0.3% | -0.1% | -1.8% | -0.4% | +0.3% | -0.2% | -0.9% | +0.2% | -0.0% | -2.1% | -0.2% | -0.4% | +0.3% | -1.2% | +0.0% | -0.6% |
| YoY Change | — | — | — | — | -0.5% | -0.8% | -2.5% | -2.5% | -1.9% | -2.1% | -1.2% | -0.6% | -0.9% | -2.8% | -2.1% | -2.7% | -2.4% | -1.5% | -1.3% | -1.6% |